Regulus Therapeutics Inc (NASDAQ:RGLS)

6.63
Data as of Oct 17
 -0.29 / -4.19%
Today’s Change
5.40
Today|||52-Week Range
11.88
-10.28%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.92
Today’s open7.04
Day’s range-- - --
Volume69,067
Average volume (3 months)64,064
Market cap$287.7M
Dividend yield--
Data as of 10/17/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-1.09-5.80%
PRQRProQR Therapeutics N...-0.02-0.16%
ACRXAcelRx Pharmaceutica...-0.61-8.30%
NWBONorthwest Biotherape...+0.05+1.10%
Data as of 10/17/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.